Coventry University Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
Bournemouth University Featured PhD Programmes

Disrupting biofilm formation in nosocomial pathogens

  • Full or part time
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

Project Description

A biofilm by definition is a structured community of bacterial cells enclosed in a self-produced polysaccharide matrix and adherent to an inert or living surface. Bacteria growing in a biofilm are between 10-1,000 times more resistant to antibiotic therapy than their planktonic counterparts. As well as an increased tolerance to antibiotics, the biofilm mode of growth offers protection from various environmental challenges such as the innate and the adaptive immune system as well as offering an increased tolerance to disinfection agents. The annual cost for biofilm infections in the USA is estimated to be $94 billion with more than half a million deaths. Due to the clinical importance of biofilms, there is an urgent need to gain a greater understanding of the regulatory cascades that govern their formation and to identify novel compounds that can inhibit their formation.

Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen associated with high morbidity and mortality in humans. P. aeruginosa is frequently isolated from patients with Cystic Fibrosis, AIDS and burns patients. In 2018, the World Health Organisation identified carbapenem-resistant P. aeruginosa as number two on the priority pathogen list for which there is an urgent need for the development of novel therapeutic strategies due increasing failure of first line antibiotics. P. aeruginosa is notorious for its ability to form biofilms both within the hospital-built environment and in immunocompromised individuals. Given the link between biofilm formation and poor treatment outcomes, the regulatory networks that control biofilm formation in P. aeruginosa are ideal targets for novel therapeutic intervention strategies.

This proposed research project aims to use high through put screening approaches to identify novel compounds that can disrupt the regulatory networks that control biofilm formation in P. aeruginosa. The mechanism of action of these candidates will then be explored using a range of classical microbiology, ‘omics and genetic approaches. Candidates that demonstrate activity against P. aeruginosa will be tested against other clinically relevant Gram-negative pathogens such as Acinetobacter baumannii. A range of model organisms will be used to determine the efficacy of these compounds in vivo.

Funding Notes

Brunel offers a number of funding options to research students that help cover the cost of their tuition fees, contribute to living expenses or both. See more information here: View Website. Recently the UK Government made available the Doctoral Student Loans of up to £25,000 for UK and EU students and there is some funding available through the Research Councils. Many of our international students benefit from funding provided by their governments or employers. Brunel alumni enjoy tuition fee discounts of 15%.)

How good is research at Brunel University London in Allied Health Professions, Dentistry, Nursing and Pharmacy?

FTE Category A staff submitted: 50.60

Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully





FindAPhD. Copyright 2005-2020
All rights reserved.